1660-1661 / 2605
Column1 Column2
Column3 Column4
Column5
Column6 Column7 Column8
Disease Site Total
Randomized / P III
P I/II P0 / Pilot / Reg
Completed
C-Ion
Breast (PB, Lymphnodes, Hodgkins,…)
14
1
9
4
2
CNS (Skull Base, Spine, Brain, …)
25
2
17
6
1
5
Eye (Melanoma, ReQnoblastoma, Mdeg,
…)
9
0
6
3
2
GI (upper GI, Esophageal, Rectum, …)
6
1
2
3
3
1
H&N Nasal Cavity, Nasopharynx,
Oropharynx,…)
20
2
7
11
5
6
Lung (NSCLC)
27
1
16
10
7
Lymphoma (Hodgkin Lymphoma, …)
4
0
1
3
1
GI (Liver)
16
2
10
4
3
GI (Pancreas)
12
0
12
0
1
1
Pediatrics (CNS, RMS, Meduloblastoma,
H&N, Brain, ...)
23
0
11
12
4
GU (Prostate)
24
8
9
7
4
1
GU (Bladder, Gyn)
2
0
1
1
0
Sarcoma (Chordoma, Chondrosarkoma,
Spine, …)
17
1
13
3
4
2
Total
199
18 114
67
37 16
* Informa4on compiled by PTCOG from par4cle therapy centers and from ClinicalTrials.gov – January 2016
Clinical Trials (acQve or completed) in ParQcle Therapy:
The PTCOG List
Note: Data form centers in Japan largely not reported to PTCOG